Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.
Medical tourism to Japan offers access to advanced healthcare, but for treatments like regenerative medicine, a key question arises: “What happens after I return home?” The success of therapies such as adipose-derived stem cell therapy depends not only on the procedure itself but also on consistent post-treatment care. For international patients, this requires a strong partnership between their treatment facility in Japan and their primary physician back home.
At Grand Green Osaka Umekita Clinic, we have established a clear protocol for care coordination. Our goal is to ensure that every international patient receives seamless, continuous medical support by actively collaborating with their local doctor. This article explains our process and why this partnership is vital for your long-term well-being.
Why Continuity of Care is Crucial for International Patients
Continuity of care is the principle of maintaining consistent, coordinated healthcare over time and across different providers. When you travel abroad for a specialized procedure, this continuity can be challenging to maintain. Without it, there’s a risk of fragmented follow-up, miscommunication about your treatment, and suboptimal management of your health journey.
For patients undergoing stem cell therapy, effective coordination is essential for monitoring progress, managing expectations, and integrating the treatment with any existing health plans. A collaborative approach between our Osaka clinic and your home physician helps bridge geographical distances, ensuring that your care remains comprehensive and informed.
Understanding Adipose-Derived Stem Cell Therapy
Adipose-derived stem cell therapy is a form of regenerative medicine that utilizes your own cells. The process involves collecting a small amount of fat tissue, from which mesenchymal stem cells (MSCs) are isolated. These cells are then cultured and expanded in number at a specialized facility before being administered back into your body, typically via an intravenous (IV) infusion.
Scientific research has reported that MSCs have several potential actions. Beyond differentiating into other cell types, they are known to secrete various bioactive molecules that can help modulate the local environment. These secretions may include anti-inflammatory substances that help calm chronic inflammation and growth factors that support the body’s own tissue repair processes. This is often called the paracrine effect.
In Japan, this treatment is provided under the Act on the Safety of Regenerative Medicine, which requires clinics to submit a detailed plan to the Ministry of Health, Labour and Welfare. This ensures a high standard of safety management. It is important to note that this is an elective treatment not covered by public health insurance. A physician must conduct a thorough consultation and examination to determine if this therapy is a suitable option for you.
Our Process for Seamless International Care Coordination
To facilitate smooth and responsible medical tourism, we have designed a structured process for collaborating with our international patients’ home physicians. Our approach is built on clear communication and shared information.
- 1. Pre-Visit Communication: Before you travel to our Osaka clinic, we encourage you to discuss your interest in stem cell therapy with your primary doctor. With your consent, we can provide them with detailed information about the proposed treatment and request relevant medical records. This initial dialogue ensures our plan aligns with your overall health status and ongoing care.
- 2. On-Site Treatment and Documentation: During your visit, our medical team will perform a comprehensive assessment, followed by the treatment. We maintain meticulous records of the entire process, from the collection of adipose tissue to the quality control of the cultured cells and their final administration.
- 3. Post-Treatment Reporting: After the therapy, we prepare a detailed medical report in English. This document summarizes the procedure performed, provides data on the administered cells, and outlines any immediate observations. This report is given to you to share with your physician, ensuring they have all the necessary clinical information.
- 4. Follow-Up Guidance: The report includes our recommendations for post-treatment monitoring. While our team remains available for consultation, this empowers your local doctor to oversee your progress effectively. This collaborative follow-up is key to managing your long-term health journey.
How to Prepare for Your Consultation in Japan
To ensure a productive consultation and facilitate effective care coordination, we recommend taking a few preparatory steps before your visit:
- Speak with Your Doctor: Inform your primary physician about your plans and confirm their willingness to participate in your follow-up care.
- Gather Your Medical Records: Prepare a summary of your medical history, a list of current medications and supplements, and any recent, relevant test results.
- Prepare Your Questions: Write down any questions or concerns you have for our medical team to ensure they are all addressed during your appointment.
Consult Our Team for Regenerative Medicine in Osaka
Embarking on a medical journey abroad is a significant decision. At Grand Green Osaka Umekita Clinic, our commitment is to provide transparent, supportive, and well-coordinated care for our international patients. The potential outcomes of adipose-derived stem cell therapy can vary between individuals, and this treatment is not presented as a cure for any disease. Its aim is to support the body’s innate capacity for repair and regulation.
A final determination of your eligibility for this treatment can only be made after a medical consultation with our physicians. For comprehensive information regarding the treatment flow, fees, potential risks, and side effects, we invite you to review our dedicated page and contact us for a consultation.
Learn more about Adipose-Derived Stem Cell Therapy- 1Pre-Visit CoordinationConsult your doctor & share info
- 2Treatment in JapanAdipose-derived stem cell therapy
- 3Medical Report ProvidedShare the report with your home doctor
- 4Follow-Up at HomeContinuous care with your home doctor
This is a simplified diagram to illustrate the care coordination process
References
- PubMed: The impact of midwifery continuity of care on maternal mental health: A narrative systematic review. (2023)
- PubMed: Continuity of care. (2022)
- PubMed: Physicians, know thy patient. (2024)
- PubMed: Continuity of Care. (2017)
- PubMed: Continuity of care with doctors-a matter of life and death? A systematic review of continuity of care and mortality. (2018)
- PMC: Predictors of outpatient follow-up care after adult emergency department asthma visits and association with 30-day outcomes. (2023)
- PMC: Patient Perspectives of Health System Barriers to Accessing Care for Hidradenitis Suppurativa: A Qualitative Study. (2023)
- PMC: Detection of Speech-Language Delay in the Primary Care Setting: An Electronic Health Record Investigation. (2023)
- MHLW (Japan): Regenerative Medicine — Ministry of Health, Labour and Welfare, Japan
Supervising Physician
Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic
Hidenori Shimada
Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.
* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.